Mushrooms, Inc. is a development stage company, which acquires and builds a portfolio of cannabis markets. The company is headquartered in Estero, Florida. The company went IPO on 2006-11-17. The company is engaged in the biotechnology and sustainable healthcare solutions using mushrooms and mycelium. The firm is focused on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries, as well as creating supplements based on the proven health benefits of mushrooms. Mycelium is a natural fiber that can be used as an alternative to plastics. Mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. The company is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. The company also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.
Follow-Up Questions
Qui est le CEO de Mushrooms Inc ?
Mr. Patrick Montalban est le Chief Executive Officer de Mushrooms Inc, il a rejoint l'entreprise depuis 2002.
Quelle est la performance du prix de l'action MSRM ?
Le prix actuel de MSRM est de $0.0229, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Mushrooms Inc ?
Mushrooms Inc appartient à l'industrie N/A et le secteur est N/A
Quelle est la capitalisation boursière de Mushrooms Inc ?
La capitalisation boursière actuelle de Mushrooms Inc est de $903.1K